Consistently, we observed that XCL1-V21C/A59C induced memory CD8+ CTL responses more efficiently than TLR ligands, as shown by the protection of mice from the challenge with OVA-expressing tumor cells after a prolonged interval [163]. This evidence concerns the gene XCL1 and neoplasm.